2nd RX-to-OTC Switch Summit

December 3 - 4, 2015
Philadelphia, PA

Navigate the Development and Commercialization of a Successful Prescription-to-OTC Switch

Brochure Conference Documentation

Prescription drugs can switch over to over-the-counter status when patents expire, but in order for this switch process to be seamless, productive and clinically safe —  and to gain market share — there needs to be a successful process in place. Additionally, when switching an RX to an OTC, you need to evaluate the regulatory environment and commercial outcomes in order to determine if this is the right process for your drug.

The 2nd RX-to-OTC Switch Summit will allow you to network with colleagues while exploring the switch process from beginning to end. Whether you are playing with the idea of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference assesses the current switch landscape in the US and beyond. It also provides a comprehensive overview of marketing trends, cutting-edge technology and regulatory developments, and is a forum for discussing lessons learned from past switches.

Top Five Reasons to Attend

  1. Understand the future of RX-to-OTC switches and how technology, advancements and proper life cycle management can accelerate them
  2. Explore key concepts that can enhance your switch implementation while gaining market position
  3. Learn how industry stakeholders can work together with key stakeholders — the FDA, retailers and dispensers, and government agencies on the switch process
  4. Explore the regulatory environment around RX-to-OTC switches
  5. Uncover ways to develop and optimize a cross-functional switch team to streamline an RX-to-OTC switch

Who Should Attend

This conference is designed for pharmaceutical, biotechnology and consumer health professionals with responsibilities in an array of areas, including:

  • Commercialization
  • Product Development
  • IT/Business Technology
  • Drug Safety
  • Regulatory
  • Packaging
  • Brand Marketing
  • Life Cycle Management
  • Labeling
  • Promotion
  • Managed Care
  • Clinical and Medical Affairs
  • Consumer Communication
  • Medical Information
  • Product Strategy
  • Legal

What Past Attendees Are Saying

“Brought up some new points that I did not think of previously.”
—Senior Director of Regulatory Affairs, PERRIGO

“Very clear, organized presentation skills, coupled with informative information.”
—Regulatory Consultant, ASTRAZENECA

 

live chat software